blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1285653

EP1285653 - Use of alpha-1L agonists in the treatment of incontinence [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  19.11.2004
Database last updated on 19.10.2024
Most recent event   Tooltip19.11.2004Application deemed to be withdrawnpublished on 05.01.2005  [2005/01]
Applicant(s)For all designated states
Boehringer Ingelheim Pharma GmbH & Co. KG
Binger Strasse 173
55218 Ingelheim am Rhein / DE
[N/P]
Former [2004/22]For all designated states
Boehringer Ingelheim Pharma GmbH & Co.KG
Binger Strasse 173
55218 Ingelheim am Rhein / DE
Former [2003/09]For all designated states
Boehringer Ingelheim Pharma KG
55216 Ingelheim am Rhein / DE
Inventor(s)01 / Esser, Franz
Posener Strasse 30
55218 Ingelheim am Rhein / DE
02 / Luettke, Sven
Am St. Jakobsberg 35
55437 Ockenheim / DE
03 / Kitagawa, Hisato
5-19-10, Kofudai, Toyono-cho
Toyono-gun, Osaka 563-0104 / JP
04 / Staehle, Helmut
Rotweinstrasse 23
55218 Ingelheim am Rhein / DE
05 / Muramatsu, Ikunobu
3-18-3, Shibahara, Matsuoka-cho
Yoshida-gun, Fukui 910-1134 / JP
06 / Uchida, Shuji
3-17-16, Ueno-Higashi
Toyonaka 560 / JP
 [2003/09]
Application number, filing date02025309.213.04.1996
[2003/09]
Priority number, dateDE199511457920.04.1995         Original published format: DE 19514579
[2003/09]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report 
No.:EP1285653
Date:26.02.2003
Language:DE
[2003/09]
Search report(s)(Supplementary) European search report - dispatched on:EP08.01.2003
ClassificationIPC:A61K31/415
[2003/09]
CPC:
C07D233/50 (EP,US); A61K31/415 (KR); A61K31/00 (EP,US);
A61K31/4164 (EP,US); A61K31/4168 (EP,US); A61K31/4178 (EP,US);
A61P13/00 (EP); A61P13/02 (EP); A61P13/10 (EP);
A61P15/00 (EP); A61P25/02 (EP); A61P43/00 (EP) (-)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2003/09]
Extension statesLT26.08.2003
LV26.08.2003
SI26.08.2003
TitleGerman:Verwendung von alpha/1L-Agonisten zur Behandlung der Harninkontinenz[2003/09]
English:Use of alpha-1L agonists in the treatment of incontinence[2003/09]
French:Utilisation de substances alpha 1L agonistes pour le traitement de l'incontinence[2003/09]
Examination procedure26.08.2003Examination requested  [2003/44]
18.12.2003Despatch of a communication from the examining division (Time limit: M06)
29.06.2004Application deemed to be withdrawn, date of legal effect  [2005/01]
04.08.2004Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2005/01]
Parent application(s)   TooltipEP96914912.9  / EP0821585
Fees paidRenewal fee
13.03.2003Renewal fee patent year 03
13.03.2003Renewal fee patent year 04
13.03.2003Renewal fee patent year 05
13.03.2003Renewal fee patent year 06
13.03.2003Renewal fee patent year 07
02.05.2003Renewal fee patent year 08
03.05.2004Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]DE2806811  (BOEHRINGER SOHN INGELHEIM) [A] 1* claim 1 *;
 [A]DE2854659  (BOEHRINGER SOHN INGELHEIM) [A] 1 * claim 1 *;
 [X]US4226773  (KYNCL JOHN J) [X] 1 * column W *;
 [A]US4287201  (OLSON GEORGE, et al) [A] 1 * column W *;
 [A]EP0070084  (BEECHAM GROUP PLC [GB]) [A] 1 * page 25 - page 26 * * claim 6 *;
 [A]EP0081923  (ALCON LAB INC [US]) [A] 1 * column W *;
 [A]EP0081924  (ALCON LAB INC [US]) [A] 1 * column W *;
 [A]EP0117102  (BEECHAM GROUP PLC [GB]) [A] 1 * example 11 *;
 [A]EP0149140  (BEECHAM GROUP PLC [GB]) [A] 1 * page 20 * * page 6 *;
 [A]US4587257  (DESANTIS LOUIS M [US], et al) [A] 1 * column W *;
 [A]EP0236636  (ALCON LAB INC [US]) [A] 1 * page 4; table 2 *;
 [X]EP0416841  (HITACHI CHEMICAL CO LTD [JP]) [X] 1,9 * column W *;
 [X]WO9408040  (SYNAPTIC PHARMA CORP [US], et al) [X] 1,9 * page 50, line 17 - line 29 * * claim 130 *;
 [X]EP0599697  (SYNTHELABO [FR]) [X] 1,9 * page 13 *;
 [XP]EP0682028  (SYNTHELABO [FR]) [XP] 1 * page 9, line 44 - line 45 * * page 9, line 6 - line 8 *;
 [X]  - J.NORDLING ET AL., "Sympathetic Influence on Striated Urethral Sphincter in Urinary Incontinence", PROG.CLIN.BIOL.RES., (1981), vol. 78, pages 101 - 103, XP000602071 [X] 1 * the whole document *
 [X]  - H.KONTANI ET AL., "Effects of Adrenergic Agonists on an Experimental Urinary Incontinence Model in Anesthetized Rabbits", JPN.J.PHARMACOL., (1992), vol. 58, no. 4, pages 339 - 346, XP000602099 [X] 1 * the whole document *
 [X]  - J.G. VAN SAVAGE ET AL., "EFFECTS OF ALPHA-ADRENERGIC AGONIST ON NEOBLADDER WATER AND ELECTROLYTE TRANSPORT", UROLOGY, (199403), vol. 43, no. 3, pages 324 - 327, XP000602098 [X] 1 * abstract *

DOI:   http://dx.doi.org/10.1016/0090-4295(94)90073-6
 [A]  - W.C.RANDALL ET AL., "MULTIPLE CENTRAL ALPHA2 ADRENOCEPTORS OF AVIAN AND MAMMALIAN SPECIES", BIOCHEM. PHARMACOL., (1983), vol. 32, no. 12, pages 1933 - 1940, XP000601225 [A] 1 * table 2 *

DOI:   http://dx.doi.org/10.1016/0006-2952(83)90061-8
Examination   - HIEBLE J. P., "Stimulation of alpha-1 and alpha-2 adrenoceptors increases urethral perfusion pressure in the pithed rat", FASEB JOURNAL, (1988), vol. 2, no. 6, page ABST8744
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.